Baker Bros. Advisors (GP) LLC
CIK 1580575
Transactions on file
144
Open-market buys
84
Win rate (buys)
81%
84 scored
Avg % since filing (buys)
+37.5%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-16 | 2026-07-14 | CELC Celcuity Inc. | Sale | 2,838,632 | $290.96M | -6.6% | open → | |
| 2026-07-16 | 2026-07-14 | CELC Celcuity Inc. | Sale | 261,368 | $26.79M | -6.6% | open → | |
| 2026-07-02 | 2026-06-30 | INCY INCYTE CORP | Grant | 400 | $0.00 | — | open → | |
| 2026-07-02 | 2026-06-30 | INCY INCYTE CORP | Grant | 400 | $0.00 | — | open → | |
| 2026-06-18 | 2026-06-17 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Grant | 908 | $0.00 | — | open → | |
| 2026-06-18 | 2026-06-17 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Grant | 908 | $0.00 | — | open → | |
| 2026-06-15 | 2026-06-11 | ONC BeOne Medicines Ltd. | Grant | 18,980 | $0.00 | — | open → | |
| 2026-06-15 | 2026-06-11 | ONC BeOne Medicines Ltd. | Grant | 18,980 | $0.00 | — | open → | |
| 2026-06-10 | 2026-06-08 | INCY INCYTE CORP | Grant | 1,642 | $0.00 | — | open → | |
| 2026-06-10 | 2026-06-08 | INCY INCYTE CORP | Grant | 1,642 | $0.00 | — | open → | |
| 2026-06-05 | 2026-06-03 | DNLI Denali Therapeutics Inc. | Grant | 6,408 | $0.00 | — | open → | |
| 2026-06-05 | 2026-06-03 | DNLI Denali Therapeutics Inc. | Grant | 6,408 | $0.00 | — | open → | |
| 2026-06-02 | 2026-05-29 | ACAD ACADIA PHARMACEUTICALS INC | Grant | 18,622 | $0.00 | — | open → | |
| 2026-06-02 | 2026-05-29 | ACAD ACADIA PHARMACEUTICALS INC | Grant | 18,622 | $0.00 | — | open → | |
| 2026-06-02 | 2026-05-29 | KNSA Kiniksa Pharmaceuticals International, plc | Grant | 6,078 | $0.00 | — | open → | |
| 2026-06-02 | 2026-05-29 | KNSA Kiniksa Pharmaceuticals International, plc | Grant | 6,078 | $0.00 | — | open → | |
| 2026-05-27 | 2026-05-22 | ONC BeOne Medicines Ltd. | Sale | 2,756 | $65.6K | +1405.9% | open → | |
| 2026-05-27 | 2026-05-22 | ONC BeOne Medicines Ltd. | Sale | 2,756 | $65.6K | +1405.9% | open → | |
| 2026-05-27 | 2026-05-22 | ONC BeOne Medicines Ltd. | Sale | 2,743 | $65.4K | +1402.1% | open → | |
| 2026-05-27 | 2026-05-22 | ONC BeOne Medicines Ltd. | Sale | 2,743 | $65.4K | +1402.1% | open → | |
| 2026-05-11 | 2026-05-08 | INCY INCYTE CORP | Exer. | 15,000 | $1.27M | +49.9% | open → | |
| 2026-05-11 | 2026-05-08 | INCY INCYTE CORP | Exer. | 15,000 | $1.27M | +49.9% | open → | |
| 2025-01-03 | 2024-12-31 | INCY INCYTE CORP | Director10% | Grant | 446 | $0.00 | — | open → |
| 2025-01-03 | 2024-12-31 | INCY INCYTE CORP | Director10% | Grant | 446 | $0.00 | — | open → |
| 2025-01-03 | 2024-12-31 | IGMS IGM Biosciences, Inc. | Director10% | Grant | 1,994 | $0.00 | — | open → |
| 2025-01-03 | 2024-12-31 | IGMS IGM Biosciences, Inc. | Director10% | Grant | 1,994 | $0.00 | — | open → |
| 2025-01-06 | 2025-01-02 | BCYC BICYCLE THERAPEUTICS PLC | Director10% | Grant | 4,400 | $0.00 | — | open → |
| 2025-01-06 | 2025-01-02 | BCYC BICYCLE THERAPEUTICS PLC | Director10% | Grant | 4,400 | $0.00 | — | open → |
| 2025-02-28 | 2025-02-28 | ONC BeiGene, Ltd. | Director | Sale | 60,851 | $15.82M | +37.8% | open → |
| 2025-02-28 | 2025-02-28 | ONC BeiGene, Ltd. | Director | Sale | 671,976 | $174.71M | +37.8% | open → |
| 2025-03-19 | 2025-03-17 | IMCR Immunocore Holdings plc | Director | Buy | 646,290 | $19.22M | +2.7% | open → |
| 2025-03-19 | 2025-03-17 | IMCR Immunocore Holdings plc | Director | Buy | 8,589 | $253.9K | +3.3% | open → |
| 2025-03-19 | 2025-03-17 | IMCR Immunocore Holdings plc | Director | Buy | 92,349 | $2.73M | +3.3% | open → |
| 2025-03-19 | 2025-03-17 | IMCR Immunocore Holdings plc | Director | Buy | 60,110 | $1.79M | +2.7% | open → |
| 2025-04-02 | 2025-03-31 | INCY INCYTE CORP | Director10% | Grant | 487 | $0.00 | — | open → |
| 2025-04-02 | 2025-03-31 | INCY INCYTE CORP | Director10% | Grant | 487 | $0.00 | — | open → |
| 2025-04-02 | 2025-03-31 | IGMS IGM Biosciences, Inc. | Director10% | Grant | 953 | $0.00 | — | open → |
| 2025-04-02 | 2025-03-31 | IGMS IGM Biosciences, Inc. | Director10% | Grant | 953 | $0.00 | — | open → |
| 2025-05-22 | 2025-05-21 | ONC BeiGene, Ltd. | Director | Grant | 21,970 | $0.00 | — | open → |
| 2025-05-22 | 2025-05-21 | ONC BeiGene, Ltd. | Director | Grant | 21,970 | $0.00 | — | open → |
| 2025-06-02 | 2025-05-29 | ACAD ACADIA PHARMACEUTICALS INC | Director10% | Grant | 16,214 | $0.00 | — | open → |
| 2025-06-02 | 2025-05-29 | ACAD ACADIA PHARMACEUTICALS INC | Director10% | Grant | 16,214 | $0.00 | — | open → |
| 2025-06-05 | 2025-06-03 | DNLI Denali Therapeutics Inc. | Director | Grant | 10,565 | $0.00 | — | open → |
| 2025-06-05 | 2025-06-03 | DNLI Denali Therapeutics Inc. | Director | Grant | 10,565 | $0.00 | — | open → |
| 2025-06-05 | 2025-06-03 | KNSA Kiniksa Pharmaceuticals International, plc | Director | Grant | 8,397 | $0.00 | — | open → |
| 2025-06-05 | 2025-06-03 | KNSA Kiniksa Pharmaceuticals International, plc | Director | Grant | 8,397 | $0.00 | — | open → |
| 2025-06-12 | 2025-06-10 | INCY INCYTE CORP | Director10% | Grant | 2,518 | $0.00 | — | open → |
| 2025-06-12 | 2025-06-10 | INCY INCYTE CORP | Director10% | Grant | 2,518 | $0.00 | — | open → |
| 2025-06-24 | 2025-06-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Director | Grant | 1,430 | $0.00 | — | open → |
| 2025-06-24 | 2025-06-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Director | Grant | 1,430 | $0.00 | — | open → |
| 2025-06-30 | 2025-06-30 | KYMR Kymera Therapeutics, Inc. | Director | Buy | 600,309 | $26.41M | +166.8% | open → |
| 2025-06-30 | 2025-06-30 | KYMR Kymera Therapeutics, Inc. | Director | Buy | 55,191 | $2.43M | +166.8% | open → |
| 2025-12-19 | 2025-12-18 | KOD Kodiak Sciences Inc. | Buy | 2,391,268 | $55.00M | +79.8% | open → | |
| 2025-12-19 | 2025-12-18 | KOD Kodiak Sciences Inc. | Buy | 217,428 | $5.00M | +79.8% | open → | |
| 2025-12-11 | 2025-12-11 | KYMR Kymera Therapeutics, Inc. | Buy | 1,838,621 | $158.12M | +36.5% | open → | |
| 2025-12-11 | 2025-12-11 | KYMR Kymera Therapeutics, Inc. | Buy | 167,192 | $14.38M | +36.5% | open → | |
| 2025-11-24 | 2025-11-20 | TRDA Entrada Therapeutics, Inc. | Buy | 13,082 | $118.7K | -21.4% | open → | |
| 2025-11-24 | 2025-11-20 | TRDA Entrada Therapeutics, Inc. | Buy | 1,186 | $10.8K | -21.4% | open → | |
| 2025-11-24 | 2025-11-20 | TRDA Entrada Therapeutics, Inc. | Buy | 13,386 | $121.4K | -21.4% | open → | |
| 2025-11-24 | 2025-11-20 | TRDA Entrada Therapeutics, Inc. | Buy | 1,213 | $11.0K | -21.4% | open → | |
| 2025-11-12 | 2025-11-12 | TRDA Entrada Therapeutics, Inc. | Buy | 11,494 | $91.4K | -10.4% | open → | |
| 2025-11-12 | 2025-11-12 | TRDA Entrada Therapeutics, Inc. | Buy | 1,040 | $8.3K | -10.4% | open → | |
| 2025-11-12 | 2025-11-12 | TRDA Entrada Therapeutics, Inc. | Buy | 80,881 | $625.3K | -7.8% | open → | |
| 2025-11-12 | 2025-11-12 | TRDA Entrada Therapeutics, Inc. | Buy | 7,321 | $56.6K | -7.8% | open → | |
| 2025-11-12 | 2025-11-11 | TRDA Entrada Therapeutics, Inc. | Buy | 30,879 | $232.8K | -5.4% | open → | |
| 2025-11-12 | 2025-11-11 | TRDA Entrada Therapeutics, Inc. | Buy | 2,795 | $21.1K | -5.4% | open → | |
| 2025-11-12 | 2025-11-11 | TRDA Entrada Therapeutics, Inc. | Buy | 11,701 | $86.5K | -3.5% | open → | |
| 2025-11-12 | 2025-11-11 | TRDA Entrada Therapeutics, Inc. | Buy | 1,059 | $7.8K | -3.5% | open → | |
| 2025-11-12 | 2025-11-10 | TRDA Entrada Therapeutics, Inc. | Buy | 2,947 | $21.3K | -1.3% | open → | |
| 2025-11-12 | 2025-11-10 | TRDA Entrada Therapeutics, Inc. | Buy | 267 | $1.9K | -1.3% | open → | |
| 2025-11-12 | 2025-11-10 | TRDA Entrada Therapeutics, Inc. | Buy | 25,364 | $183.0K | -1.2% | open → | |
| 2025-11-12 | 2025-11-10 | TRDA Entrada Therapeutics, Inc. | Buy | 2,296 | $16.6K | -1.2% | open → | |
| 2025-10-02 | 2025-10-01 | KALA KALA BIO, Inc. | Sale | 462,967 | $640.7K | — | open → | |
| 2025-10-02 | 2025-10-01 | KALA KALA BIO, Inc. | Sale | 50,640 | $70.1K | — | open → | |
| 2025-10-02 | 2025-09-30 | KALA KALA BIO, Inc. | Sale | 195,425 | $311.9K | — | open → | |
| 2025-10-02 | 2025-09-30 | KALA KALA BIO, Inc. | Sale | 21,376 | $34.1K | — | open → | |
| 2025-10-02 | 2025-09-30 | INCY INCYTE CORP | Grant | 388 | $0.00 | — | open → | |
| 2025-10-02 | 2025-09-30 | INCY INCYTE CORP | Grant | 388 | $0.00 | — | open → | |
| 2025-07-02 | 2025-06-30 | INCY INCYTE CORP | Director10% | Grant | 492 | $0.00 | — | open → |
| 2025-07-02 | 2025-06-30 | INCY INCYTE CORP | Director10% | Grant | 492 | $0.00 | — | open → |
| 2025-07-02 | 2025-06-30 | IGMS IGM Biosciences, Inc. | Director10% | Grant | 953 | $0.00 | — | open → |
| 2025-07-02 | 2025-06-30 | IGMS IGM Biosciences, Inc. | Director10% | Grant | 953 | $0.00 | — | open → |
| 2025-08-18 | 2025-08-14 | IGMS IGM Biosciences, Inc. | Other | U | 3,763,362 | — | — | open → |
| 2025-08-18 | 2025-08-14 | IGMS IGM Biosciences, Inc. | Other | U | 357,048 | — | — | open → |
| 2025-08-20 | 2025-08-18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Director | Buy | 2,747 | $1.01M | +46.5% | open → |
| 2025-08-20 | 2025-08-18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Director | Buy | 933 | $347.2K | +45.4% | open → |
| 2025-08-20 | 2025-08-18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Director | Buy | 10,128 | $3.77M | +45.4% | open → |
| 2025-08-20 | 2025-08-18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Director | Buy | 177 | $62.6K | +52.9% | open → |
| 2025-08-20 | 2025-08-18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Director | Buy | 1,923 | $680.5K | +52.9% | open → |
| 2025-08-20 | 2025-08-18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Director | Buy | 84 | $29.8K | +52.4% | open → |
| 2025-08-20 | 2025-08-18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Director | Buy | 916 | $325.2K | +52.4% | open → |
| 2025-08-20 | 2025-08-18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Director | Buy | 767 | $273.8K | +51.6% | open → |
| 2025-08-20 | 2025-08-18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Director | Buy | 8,328 | $2.97M | +51.6% | open → |
| 2025-08-20 | 2025-08-18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Director | Buy | 228 | $81.7K | +51.1% | open → |
| 2025-08-20 | 2025-08-18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Director | Buy | 2,472 | $885.5K | +51.1% | open → |
| 2025-08-20 | 2025-08-18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Director | Buy | 784 | $281.8K | +50.6% | open → |
| 2025-08-20 | 2025-08-18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Director | Buy | 8,514 | $3.06M | +50.6% | open → |
| 2025-08-20 | 2025-08-18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Director | Buy | 502 | $181.4K | +49.7% | open → |
| 2025-08-20 | 2025-08-18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Director | Buy | 5,443 | $1.97M | +49.7% | open → |
| 2025-08-20 | 2025-08-18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Director | Buy | 515 | $186.6K | +49.3% | open → |
